Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study

Cited by (1,000)

Items 201–300 of 1,000

1. Receipt of opioid use disorder treatments prior to fatal overdoses and comparison to no treatment in Connecticut, 2016–17
   Robert Heimer, Anne C. Black, Hsiu‐Ju Lin, Lauretta E. Grau, David A. Fiellin, Benjamin A. Howell, Kathryn F. Hawk, Gail D’Onofrio, William C. Becker · 2023 · Drug and Alcohol Dependence
2. The addiction consultation service for hospitalized patients with substance use disorder: An integrative review of the evidence
   Itai Danovitch, Samuel Korouri, Harlene Kaur, Gabrielle Messineo, Teryl K. Nuckols, Waguih William IsHak, Allison J. Ober · 2024 · Journal of Substance Use and Addiction Treatment
3. A scalable, automated warm handoff from the emergency department to community sites offering continued medication for opioid use disorder: Lessons learned from the EMBED trial stakeholders
   Osama M. Ahmed, Jodi A Mao, Stephen R. Holt, Kathryn F. Hawk, Gail D’Onofrio, Shara H. Martel, Edward R. Melnick · 2019 · Journal of Substance Abuse Treatment
4. Operationalizing and selecting outcome measures for the HEALing Communities Study
   Svetla S. Slavova, Marc R. Larochelle, Elisabeth Dowling Root, Daniel J. Feaster, Jennifer Villani, Charles E. Knott, Jeffery Talbert, Aimee Mack, Dushka A. Crane, Dana Bernson et al. · 2020 · Drug and Alcohol Dependence
5. Shorter outpatient wait-times for buprenorphine are associated with linkage to care post-hospital discharge
   Payel Jhoom Roy, Ryan Price, Sugy Choi, Zoe Weinstein, Edward Bernstein, Chinazo O. Cunningham, Alexander Yale Walley · 2021 · Drug and Alcohol Dependence
6. Differential impacts of COVID-19 across racial-ethnic identities in persons with opioid use disorder
   Colleen B. Mistler, Matthew C. Sullivan, Michael M. Copenhaver, Jaimie P. Meyer, Alexis M. Roth, Sheela Shenoi, Eva Jennifer Edelman, Jeffrey A. Wickersham, Roman Shrestha · 2021 · Journal of Substance Abuse Treatment
7. Association Between Buprenorphine for Opioid Use Disorder and Mortality Risk
   J. Priyanka Vakkalanka, Brian C. Lund, Stephan V. Arndt, William Field, Mary E. Charlton, Marcia M. Ward, Ryan M. Carnahan · 2021 · American Journal of Preventive Medicine
8. “This is part of emergency medicine now”: A qualitative assessment of emergency clinicians’ facilitators of and barriers to initiating buprenorphine
   Elizabeth M. Schoenfeld, William E. Soares, Emily M. Schaeffer, Jacob A Gitlin, Kimberly Burke, Lauren M. Westafer · 2021 · Academic Emergency Medicine
9. Treatment preference for opioid use disorder among people who are incarcerated
   Eliana R Kaplowitz, Ashley Q. Truong, Justin Berk, Rosemarie A. Martin, Jennifer G. Clarke, Morgan Wieck, Josiah D. Rich, Lauren Brinkley‐Rubinstein · 2021 · Journal of Substance Abuse Treatment
10. Variation in Initiation, Engagement, and Retention on Medications for Opioid Use Disorder Based on Health Insurance Plan Design
    Morgan, Jake R., Quinn, Emily K., Chaisson, Christine E., Ciemins, Elizabeth, Stempniewicz, Nikita, White, Laura F., Linas, Benjamin P., Walley, Alexander Y., LaRochelle, Marc R. · 2022 · Medical Care
11. Buprenorphine Treatment For Opioid Use Disorder: Comparison Of Insurance Restrictions, 2017–21
    Barbara Andraka‐Christou, Kosali Ilayperuma Simon, W. David Bradford, Thuy Dieu Nguyen · 2023 · Health Affairs
12. U.S. substance use harm reduction efforts: a review of the current state of policy, policy barriers, and recommendations
    Bailey E. Pridgen, Andrew P. Bontemps, Audrey R. Lloyd, William P. Wagner, Emma Sophia Kay, Ellen Eaton, Karen L. Cropsey · 2025 · Harm Reduction Journal
13. Optimizing the impact of medications for opioid use disorder at release from prison and jail settings: A microsimulation modeling study
    Alexandria Macmadu, Joëlla W. Adams, Sam E. Bessey, Lauren Brinkley‐Rubinstein, Rosemarie A. Martin, Jennifer G. Clarke, Traci Craig Green, Josiah D. Rich, Brandon D. L. Marshall · 2020 · International Journal of Drug Policy
14. Interventions for Hospitalized Medical and Surgical Patients with Opioid use Disorder: A Systematic Review
    Rachel French, Shoshana V. Aronowitz, Jacqueline Margo Brooks Carthon, Heath D. Schmidt, Peggy A Compton · 2021 · Substance Abuse
15. Harm reduction for the treatment of patients with severe injection-related infections: description of the Jackson SIRI Team
    David Phillip Serota, Hansel E. Tookes, Belén Hervera, Babley M. Gayle, Cara R. Roeck, Edward Suarez, David W. Forrest, Michael A. Kolber, Tyler S. Bartholomew, Allan E. Rodriguez et al. · 2021 · Annals of Medicine
16. Models for Implementing Emergency Department–Initiated Buprenorphine With Referral for Ongoing Medication Treatment at Emergency Department Discharge in Diverse Academic Centers
    Lauren Whiteside, Gail D’Onofrio, David A. Fiellin, Eva Jennifer Edelman, Lynne D. Richardson, Patrick G. O’Connor, Richard Eric Rothman, Ethan A. Cowan, Michael S. Lyons, Callan Elswick Fockele et al. · 2022 · Annals of Emergency Medicine
17. Mechanism of opioid addiction and its intervention therapy: Focusing on the reward circuitry and mu‐opioid receptor
    Jia‐Jia Zhang, Changgeng Song, Jimin Dai, Ling Li, Xiangmin Yang, Zhi‐Nan Chen · 2022 · MedComm
18. Top Ten Tips Palliative Care Clinicians Should Know About Buprenorphine
    Kyle Neale, Melissa B. Weimer, Mellar P. Davis, Katie Fitzgerald Jones, Justin G. Kullgren, Sachin S. Kale, Julie Wilson Childers, Kathleen Broglio, Jessica S. Merlin, Sarah Peck et al. · 2022 · Journal of Palliative Medicine
19. Buprenorphine prescribing for opioid use disorder in medical practices: can office‐based out‐patient care address the opiate crisis in the United States?
    Taeho Greg Rhee, Robert Alan Rosenheck · 2019 · Addiction
20. Physician attitudes on buprenorphine induction in the emergency department: results from a multistate survey
    Matthew D. Zuckerman, Timothy Kelly, Kennon J Heard, Amy E. Zosel, Michael Brett Marlin, Jason A. Hoppe · 2020 · Clinical Toxicology
21. A qualitative study of big data and the opioid epidemic: recommendations for data governance
    Elizabeth Evans, Elizabeth Delorme, Karl D. Cyr, Daniel M. Goldstein · 2020 · BMC Medical Ethics
22. Association of Implementation of Postoverdose Outreach Programs With Subsequent Opioid Overdose Deaths Among Massachusetts Municipalities
    Ziming Xuan, Shapei Yan, Scott W. Formica, Traci C. Green, Leo A. Beletsky, David Rosenbloom, Sarah Mary Bagley, Simeon D. Kimmel, Jennifer J. Carroll, Audrey M. Lambert et al. · 2023 · JAMA Psychiatry
23. Effect of lowering initiation thresholds in a primary care-based buprenorphine treatment program
    Bjorn E. Payne, Jared Wilson Klein, Claire B. Simon, Jocelyn R. James, Sara L. Jackson, Joseph O. Merrill, Rui Zhuang, Judith I. Tsui · 2019 · Drug and Alcohol Dependence
24. Beliefs about medications for opioid use disorder among Florida criminal problem-solving court & dependency court staff
    Barbara Andraka‐Christou, Danielle N. Atkins · 2020 · The American Journal of Drug and Alcohol Abuse
25. Race, ethnicity, and emergency department post-overdose care
    Neha G. Reddy, Brendan P. Jacka, Hannah N. Ziobrowski, Taneisha T. Wilson, Alexis C Lawrence, Francesca L. Beaudoin, Elizabeth A. Samuels · 2021 · Journal of Substance Abuse Treatment
26. Experiences with an Addiction Consultation Service on Care Provided to Hospitalized Patients with Opioid use Disorder: A Qualitative Study of Hospitalists, Nurses, Pharmacists, and Social Workers
    Catherine Callister, Steven Lockhart, Jodi Summers Holtrop, Kaitlyn Hoover, Susan L. Calcaterra · 2021 · Substance Abuse
27. Opioid Use in Pregnancy: A Review
    Kimberly S. Ryan, Kristin C. Prewitt, Sarena Hayer, Madeline A. Hedges, Ashley E. Benson, Jamie Oi-Ting Lo · 2023 · Obstetrical & Gynecological Survey
28. Chapter 13. Methadone and Buprenorphine Maintenance Treatment of Opioid-Related Disorders
    Eric C. Strain, Kenneth B. Stoller · 2021 · American Psychiatric Association Publishing eBooks
29. The association between buprenorphine treatment duration and mortality: a multi‐site cohort study of people who discontinued treatment
    Jason M. Glanz, Ingrid A. Binswanger, Christina L. Clarke, Anh P. Nguyen, Morgan A. Ford, Gary Thomas Ray, Stanley Xu, Rulin C. Hechter, Bobbi Jo H. Yarborough, Douglas W. Roblin et al. · 2022 · Addiction
30. Healthcare provider stigma toward patients with substance use disorders
    Carrigan Leigh Parish, Daniel J. Feaster, Harold A. Pollack, Viviana E. Horigian, Xiaoming Wang, Petra Jacobs, Margaret R. Pereyra, Christina Drymon, E.M. Allen, Lauren K. Gooden et al. · 2025 · Addiction
31. Barriers to Medications for Opioid Use Disorder Among Veterans Involved in the Legal System: a Qualitative Study
    Andrea K. Finlay, Erica Ferro Morse, Matthew A. Stimmel, Emmeline N. Taylor, Christine Timko, Alex H. S. Harris, David A. Smelson, Mengfei Yu, Jessica Blue‐Howells, Ingrid A. Binswanger · 2020 · Journal of General Internal Medicine
32. Linking MATTERS: Barriers and Facilitators to Implementing Emergency Department-Initiated Buprenorphine-Naloxone in Patients with Opioid Use Disorder and Linkage to Long-Term Care
    Randi G. Sokol, Elizabeth Tammaro, Ja Young Kim, Thomas J. Stopka · 2021 · Substance Use & Misuse
33. Facilitators and barriers to post-overdose service delivery in Rhode Island emergency departments: A qualitative evaluation
    Alexandra B. Collins, Francesca L. Beaudoin, Elizabeth A. Samuels, Rachel Wightman, Janette B. Baird · 2021 · Journal of Substance Abuse Treatment
34. Prevalence and correlates of non-fatal overdose among people who use drugs: findings from rapid assessments in Massachusetts, 2017–2019
    Shikhar Shrestha, Thomas J. Stopka, Jaclyn M. W. Hughto, Patricia Case, Wilson R. Palacios, Brittni Reilly, Traci C. Green · 2021 · Harm Reduction Journal
35. Individual, interpersonal, and neighborhood measures associated with opioid use stigma: Evidence from a nationally representative survey
    Qinyun Lin, Marynia Kolak, Beth Watts, Luc Anselin, Harold A. Pollack, John A. Schneider, Bruce G. Taylor · 2022 · Social Science & Medicine
36. Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts
    Avik Chatterjee, Michelle Weitz, Alexandra A. Savinkina, Alexandria Macmadu, Rajapaksha W. M. A. Madushani, Ruth A. Potee, Danielle Ryan, Sean M. Murphy, Alexander Yale Walley, Benjamin Paul Linas · 2023 · JAMA Network Open
37. Rapid induction onto sublingual buprenorphine after opioid overdose and successful linkage to treatment for opioid use disorder
    Andrew A. Herring, Cody W. Schultz, Elaine Yang, Mark K. Greenwald · 2019 · The American Journal of Emergency Medicine
38. Illicit Substance Use and Treatment Access Among Adults Experiencing Homelessness
    Ryan D. Assaf, Meghan D. Morris, Elana R. Straus, Priest Martinez, Morgan Mari Philbin, Margot Kushel · 2025 · JAMA
39. The Affordable Care Act In The Heart Of The Opioid Crisis: Evidence From West Virginia
    Brendan K. Saloner, Rachel K. Landis, Bradley D. Stein, Colleen L. Barry · 2019 · Health Affairs
40. An integrated web application for decision support and automation of EHR workflow: a case study of current challenges to standards-based messaging and scalability from the EMBED trial
    Edward R. Melnick, Wesley C. Holland, Osama M. Ahmed, Anthony K. Ma, Sean S. Michael, Howard Goldberg, Christian Lagier, Gail D’Onofrio, Tomek Stachowiak, Cynthia Brandt et al. · 2019 · JAMIA Open
41. Diagnosis and Management of Opioid Use Disorder in Hospitalized Patients
    Michael Herscher, Matthew Fine, Reema Navalurkar, Leeza Hirt, Linda Wang · 2020 · Medical Clinics of North America
42. The design and conduct of a randomized clinical trial comparing emergency department initiation of sublingual versus a 7-day extended-release injection formulation of buprenorphine for opioid use disorder: Project ED Innovation
    Gail D’Onofrio, Kathryn F. Hawk, Andrew A. Herring, Jeanmarie Perrone, Ethan A. Cowan, Ryan P. McCormack, James D Dziura, Richard Andrew Taylor, Edouard Coupet, Eva Jennifer Edelman et al. · 2021 · Contemporary Clinical Trials
43. Emergency department‐initiated buprenorphine protocols: A national evaluation
    Clara Z. Guo, Gail D’Onofrio, David A. Fiellin, Eva Jennifer Edelman, Kathryn F. Hawk, Andrew A. Herring, Ryan P. McCormack, Jeanmarie Perrone, Ethan A. Cowan · 2021 · Journal of the American College of Emergency Physicians Open
44. Suicidal motivations among opioid overdose survivors: Replication and extension
    Hilary Smith Connery, Roger D. Weiss, Margaret L. Griffin, Catherine D. Trinh, Jungjin Kim, Ian R. H. Rockett, R. Kathryn McHugh · 2022 · Drug and Alcohol Dependence
45. Analysis of Stimulant Prescriptions and Drug-Related Poisoning Risk Among Persons Receiving Buprenorphine Treatment for Opioid Use Disorder
    Carrie M. Mintz, Kevin Y. Xu, Ned J. Presnall, Sarah M. Hartz, F. Levin, Jeffrey F. Scherrer, L. Bierut, R. Grucza · 2022 · JAMA Network Open
46. The Effect of Naloxone Access Laws on Fatal Synthetic Opioid Overdose Fatality Rates
    Mohammad Tabatabai, Robert Lyle Cooper, Derek M. Wilus, Ryan D. Edgerton, Aramandla Ramesh, Samuel A. MacMaster, Parul N. Patel, Karan P. Singh · 2023 · Journal of Primary Care & Community Health
47. State alignment with federal regulations in 2022 to relax buprenorphine 30-patient waiver requirements
    Anita Silwal, Jeffery Talbert, Robert M. Bohler, Jordan Kelsch, Christopher Cook, Derek Blevins, Molly Gallivan, Timothy Hunt, Sarah M. Hatcher, Cindy Lou Parks et al. · 2023 · Drug and Alcohol Dependence Reports
48. Drug use patterns and factors related to the use and discontinuation of medications for opioid use disorder in the age of fentanyl: findings from a mixed-methods study of people who use drugs
    Jaclyn M. W. Hughto, Abigail R. Tapper, Sabrina S. Rapisarda, Thomas J. Stopka, Wilson R. Palacios, Patricia Case, Joseph Silcox, Patience Moyo, Traci C. Green · 2023 · Substance Abuse Treatment Prevention and Policy
49. Improve Access to Care for Opioid Use Disorder: A Call to Eliminate the X-Waiver Requirement Now
    Gail D’Onofrio, Edward R. Melnick, Kathryn F. Hawk · 2021 · Annals of Emergency Medicine
50. Undertreatment of opioid use disorder in patients hospitalized with injection drug use-associated infections
    Elana S. Rosenthal, Christopher J Brokus, Junfeng Sun, Joseph Edward Carpenter, Jillian S. Catalanotti, Ellen Eaton, Alaina Steck, Irene C. Kuo, Greer Burkholder, Hana Akselrod et al. · 2023 · AIDS
51. Mobile treatment for opioid use disorder: Implementation of community-based, same-day medication access interventions
    Avik Chatterjee, Trevor J. Baker, Maria Rudorf, Galya Walt, Caroline Stotz, Anna Martin, Elizabeth N. Kinnard, Ann Scheck McAlearney, Julie Bosak, Bethany Medley et al. · 2023 · Journal of Substance Use and Addiction Treatment
52. Medications for Opioid Use Disorder in County Jails — Outcomes after Release
    Peter D. Friedmann, Donna Wilson, Thomas J. Stopka, Dana Bernson, Ekaterina Pivovarova, Warren J. Ferguson, Randall A. Hoskinson, Rebecca E. Rottapel, Benjamin J. Bovell-Ammon, Ayorkor Gaba et al. · 2025 · New England Journal of Medicine
53. Who Receives Naloxone from Emergency Medical Services? Characteristics of Calls and Recent Trends
    Caroline K. Geiger, Rosanna Smart, Bradley D. Stein · 2019 · Substance Abuse
54. A randomized clinical trial of a theory-based fentanyl overdose education and fentanyl test strip distribution intervention to reduce rates of opioid overdose: study protocol for a randomized controlled trial
    Brendan P. Jacka, Jacqueline A. Goldman, Jesse L. Yedinak, Edward Bernstein, Scott Evan Hadland, Jane A. Buxton, Susan G. Sherman, Katie B. Biello, Brandon D. L. Marshall · 2020 · Trials
55. Opioid overdose in the age of fentanyl: Risk factor differences among subpopulations of overdose survivors
    Anna Kline, Dina Mattern, Nina A. Cooperman, Jill M. Williams, Patricia Dooley Budsock, Ralph Foglia, Suzanne V. Borys · 2020 · International Journal of Drug Policy
56. Increasing Preference for Fentanyl among a Cohort of People who use Opioids in Vancouver, Canada, 2017-2018
    Sarah Ickowicz, Thomas H Kerr, Cameron J Grant, M‐J Milloy, Evan Wood, Kanna Hayashi · 2021 · Substance Abuse
57. Low Dose Buprenorphine Induction With Full Agonist Overlap in Hospitalized Patients With Opioid Use Disorder: A Retrospective Cohort Study
    Elenore P. Bhatraju, Jared W. Klein, Allana N. Hall, David R. Chen, Matthew Iles-Shih, Judith I. Tsui, Joseph O. Merrill · 2021 · Journal of Addiction Medicine
58. Patient- and Provider-Reported Experiences of a Mobile Novel Digital Therapeutic in People With Opioid Use Disorder (reSET-O): Feasibility and Acceptability Study
    Sarah Sharfstein Kawasaki, Sara L. Mills-Huffnagle, Nicole Aydinoglo, Halley Maxin, Edward V. Nunes · 2022 · JMIR Formative Research
59. Stigma by Association: To what Extent is the Attitude Toward Naloxone Affected by the Stigma of Opioid Use Disorder?
    Samuel Olusegun Adeosun · 2022 · Journal of Pharmacy Practice
60. Tailoring dissemination strategies to increase evidence-informed policymaking for opioid use disorder treatment: study protocol
    Erika L. Crable, Colleen M. Grogan, Jonathan Purtle, Scott C. Roesch, Gregory A. Aarons · 2023 · Implementation Science Communications
61. Adaptation of the Tele-Harm Reduction intervention to promote initiation and retention in buprenorphine treatment among people who inject drugs: a retrospective cohort study
    Edward Suarez, Tyler S. Bartholomew, Marina Plesons, Katrina J. Ciraldo, Lily Ostrer, David Phillip Serota, Teresa A. Chueng, Morgan Frederick, Jason Onugha, Hansel E. Tookes · 2023 · Annals of Medicine
62. Caring for Our Patients With Opioid Use Disorder in the Perioperative Period: A Guide for the Anesthesiologist
    Antje M. Barreveld, Andrew M. Mendelson, Brittany Leigh Deiling, Catharina A. Armstrong, Eugene R. Viscusi, Lynn R Kohan · 2023 · Anesthesia & Analgesia
63. Low-threshold Buprenorphine Treatment in a Syringe Services Program: Program Description and Outcomes.
    Andrea U. Jakubowski, Brianna L. Norton, Benjamin T. Hayes, Brent E. Gibson, Christine Fitzsimmons, L Synn Stern, Franklin Ramirez, Mercedes Guzman, Susan E. Spratt, Pia Marcus et al. · 2022 · PubMed
64. Association of Daily Doses of Buprenorphine With Urgent Health Care Utilization
    Sarah Axeen, Rosalie Liccardo Pacula, Jessica S. Merlin, Adam J. Gordon, Bradley D. Stein · 2024 · JAMA Network Open
65. Comparing Buprenorphine-Prescribing Physicians Across Nonmetropolitan and Metropolitan Areas in the United States
    Lewei Allison Lin, Hannah K. Knudsen · 2019 · The Annals of Family Medicine
66. Buprenorphine treatment for opioid use disorder: recent progress
    Suprit Parida, Kathleen M. Carroll, Ismene L. Petrakis, Mehmet Sofuoglu · 2019 · Expert Review of Clinical Pharmacology
67. Factors associated with help seeking by community responders trained in overdose prevention and naloxone administration in Massachusetts
    Jamie K. Lim, Leah S. Forman, Sarah Ruiz, Ziming Xuan, Barry P. Callis, Kevin Cranston, Alexander Yale Walley · 2019 · Drug and Alcohol Dependence
68. Emergency Department Initiation of Buprenorphine for Opioid Use Disorder: Current Status, and Future Potential
    Lindsay Fox, Lewis S. Nelson · 2019 · CNS Drugs
69. The relationship between opioid agonist therapy satisfaction and fentanyl exposure in a Canadian setting
    Lindsay Mackay, Thomas H Kerr, Nadia S. Fairbairn, Cameron Charles Grant, M‐J Milloy, Kanna Hayashi · 2021 · Addiction Science & Clinical Practice
70. The relationship between crystal methamphetamine use and methadone retention in a prospective cohort of people who use drugs
    Lindsay Mackay, Paxton Bach, M‐J Milloy, Zishan Cui, Thomas H Kerr, Kanna Hayashi · 2021 · Drug and Alcohol Dependence
71. Long-acting buprenorphine injectables: Opportunity to improve opioid use disorder treatment among rural populations
    Michelle R. Lofwall, Laura C. Fanucchi · 2021 · Preventive Medicine
72. Adjunct interventions to standard medical management of buprenorphine in outpatient settings: A systematic review of the evidence
    Jessica J. B. Wyse, Benjamin J. Morasco, Jacob Dougherty, Beau Edwards, Devan L. Kansagara, Adam J. Gordon, Philip Todd Korthuis, Anaïs Tuepker, Stephan Lindner, Katherine Mackey et al. · 2021 · Drug and Alcohol Dependence
73. Placing Racial Equity at the Center of Substance Use Research: Lessons From the HEALing Communities Study
    Avik Chatterjee, LaShawn Glasgow, Mackenzie Bullard, Mariah Sabir, Greer A. Hamilton, Deborah Chassler, Danelle J. Stevens-Watkins, Dawn Goddard‐Eckrich, Emma Rodgers, Joan Chaya et al. · 2022 · American Journal of Public Health
74. Sleep Deficiency and Opioid Use Disorder
    Jennifer Langstengel, Henry Klar Yaggi · 2022 · Clinics in Chest Medicine
75. Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes
    Erin Audrey Taylor, Jonathan Cantor, Ashley C. Bradford, Kosali Ilayperuma Simon, Bradley D. Stein · 2023 · JAMA Network Open
76. A predictive risk model for nonfatal opioid overdose in a statewide population of buprenorphine patients
    Hsien‐Yen Chang, Noa Krawczyk, Kristin E. Schneider, Lindsey M. Ferris, Matthew D. Eisenberg, Tom M. Richards, Brianna Casey Lyons, Kate Jackson, Jonathan P. Weiner, Brendan K. Saloner · 2019 · Drug and Alcohol Dependence
77. Changes in Outpatient Services and Medication Use Following a Non-fatal Opioid Overdose in the West Virginia Medicaid Program
    Neel Koyawala, Rachel K. Landis, Colleen L. Barry, Bradley D. Stein, Brendan K. Saloner · 2019 · Journal of General Internal Medicine
78. U.S. Emergency Department Visits Resulting From Nonmedical Use of Pharmaceuticals, 2016
    Andrew Isaac Geller, Deborah Dowell, Maribeth C. Lovegrove, Jana McAninch, Sandra K. Goring, Kathleen O. Rose, Nina J. Weidle, Daniel S. Budnitz · 2019 · American Journal of Preventive Medicine
79. Supporting individuals using medications for opioid use disorder in recovery residences: challenges and opportunities for addressing the opioid epidemic
    Jennifer Miles, Jason Howell, Dave Sheridan, George S. Braucht, Amy A. Mericle · 2020 · The American Journal of Drug and Alcohol Abuse
80. Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder
    Flam-Ross, Juliet M., Marsh, Elizabeth, Weitz, Michelle, Savinkina, Alexandra, Schackman, Bruce R., Wang, Jianing, Madushani, R. W. M. A., Morgan, Jake R., Barocas, Joshua A., Walley, Alexander Y. et al. · 2023 · JAMA Network Open
81. Monitoring opioid addiction and treatment: Do you know if your population is engaged?
    José Tomás Prieto, Dean McEwen, Arthur J. Davidson, Alia Al‐Tayyib, Lisa Gawenus, Sridhar R. Papagari Sangareddy, Joshua Blum, Seth L. Foldy, Judith C. Shlay · 2019 · Drug and Alcohol Dependence
82. Endogenous Opiates and Behavior: 2018
    Richard J. Bodnar · 2020 · Peptides
83. Familial perceptions of appropriate treatment types and goals for a family member who has opioid use disorder
    Sandeep Manel Nayak, Andrew S. Huhn, Cecilia L. Bergeria, Eric C. Strain, Kelly E. Dunn · 2021 · Drug and Alcohol Dependence
84. Illicit Drug Use in Older Adults
    Ziad Ghantous, Victoria Ahmad, Rita Khoury · 2021 · Clinics in Geriatric Medicine
85. Opioid overdose survivors: Medications for opioid use disorder and risk of repeat overdose in Medicaid patients
    Stephen Crystal, Molly Nowels, Hillary Samples, Mark Olfson, Arthur Robin Williams, Peter C. Treitler · 2022 · Drug and Alcohol Dependence
86. Centering culture in the treatment of opioid use disorder with American Indian and Alaska Native Communities: Contributions from a National Collaborative Board
    Katherine A. Hirchak, Mélanie Nadeau, Ángel Vásquez, Alexandra Hernandez‐Vallant, Kyle Smith, Cuong Pham, Karen Anderson Oliver, Paulette Baukol, Karen Lizzy, Racquel Shaffer et al. · 2022 · American Journal of Community Psychology
87. Facilitating factors and barriers for use of medications to treat opioid use disorder (MOUD) among justice‐involved individuals in rural Appalachia
    Michele Staton, Erika Pike, Martha D. Tillson, Michelle R. Lofwall · 2023 · Journal of Community Psychology
88. Early emergency department experience with 7‐day extended‐release injectable buprenorphine for opioid use disorder
    Gail D’Onofrio, Jeanmarie Perrone, Kathryn F. Hawk, Ethan A. Cowan, Ryan P. McCormack, Edouard Coupet, Patricia H. Owens, Shara H. Martel, Kristen Huntley, SHARON L. WALSH et al. · 2023 · Academic Emergency Medicine
89. Unprecedented need and recommendations for harnessing data to guide future policy and practice for opioid use disorder treatment following COVID-19
    Nicholas A. Livingston, Victoria Ameral, Anne N. Banducci, Risa B. Weisberg · 2020 · Journal of Substance Abuse Treatment
90. Overdose, Behavioral Health Services, and Medications for Opioid Use Disorder After a Nonfatal Overdose
    Christopher McCall Jones, Carla M. Shoff, Carlos Blanco, Jan L. Losby, Shari M. Ling, Wilson M. Compton · 2024 · JAMA Internal Medicine
91. The opioid crisis and the 2020 US election: crossroads for a national epidemic
    Leana S. Wen, Nakisa B. Sadeghi · 2020 · The Lancet
92. Perioperative Management of Buprenorphine/Naloxone in a Large, National Health Care System: a Retrospective Cohort Study
    Jessica J. B. Wyse, Anders Herreid-O’Neill, Jacob Dougherty, Sarah Shull, Katherine Mackey, Kelsey C. Priest, Honora L. Englander, Jessica Thoma, Travis I. Lovejoy · 2021 · Journal of General Internal Medicine
93. Compassion, stigma, and professionalism among emergency personnel responding to the opioid crisis: An exploratory study in New Hampshire, USA
    Stephen A. Metcalf, Elizabeth C. Saunders, Sarah K. Moore, Olivia Walsh, Andrea Meier, Samantha G. Auty, Sarah Y. Bessen, Lisa A. Marsch · 2022 · Journal of the American College of Emergency Physicians Open
94. Opioid Use Disorder, Sleep Deficiency, and Ventilatory Control: Bidirectional Mechanisms and Therapeutic Targets
    Danny Joel Eckert, Henry Klar Yaggi · 2022 · American Journal of Respiratory and Critical Care Medicine
95. Barriers and facilitators to the use of medication for opioid use disorder within the criminal justice system: Perspectives from clinicians
    Marisa D. Booty, Kathi L.H. Harp, Evan J. Batty, Hannah K. Knudsen, Michele Staton, Carrie B. Oser · 2023 · Journal of Substance Use and Addiction Treatment
96. Accessibility of Opioid Treatment Programs Based on Conventional vs Perceived Travel Time Measures
    Junghwan Kim, Jinhyung Lee, Thomas A. Thornhill IV, Julia M. Dennett, Haidong Lu, Benjamin A. Howell, Lauretta E. Grau, David A. Fiellin, Robert Heimer, Gregg Gonsalves · 2024 · JAMA Network Open
97. Prison Buprenorphine Implementation and Postrelease Opioid Use Disorder Outcomes
    Benjamin J. Bovell-Ammon, Shapei Yan, Devon Dunn, Elizabeth Evans, Peter D. Friedmann, Alexander Yale Walley, Marc R. Larochelle · 2024 · JAMA Network Open
98. A Resident‐Led Intervention to Increase Initiation of Buprenorphine Maintenance for Hospitalized Patients With Opioid Use Disorder
    Ashish P. Thakrar, David M. Furfaro, Sara C. Keller, Ryan Graddy, Megan E. Buresh, Leonard Samuel Feldman · 2021 · Journal of Hospital Medicine
99. Toward a Typology of Office-based Buprenorphine Treatment Laws: Themes From a Review of State Laws
    Barbara Andraka‐Christou, Adam J. Gordon, Kathryn Bouskill, Rosanna Smart, Olivia K. Golan, Matthew Golan, Rachel Totaram, Bradley D. Stein · 2021 · Journal of Addiction Medicine
100. An examination between treatment type and treatment retention in persons with opioid and co-occurring alcohol use disorders
     Carrie M. Mintz, Ned J. Presnall, Kevin Young Xu, Sarah M. Hartz, John M. Sahrmann, Laura Jean Bierut, Richard A. Grucza · 2021 · Drug and Alcohol Dependence